Outcomes of patients with hepatocellular carcinoma are determined in multidisciplinary team meetings

Bérénice Charriere1, Fabrice Muscari1, Charlotte Maulat1

  • 1Service de chirurgie digestive et hépatobiliaire, Centre Hospitalier Universitaire Rangueil, Université Paul Sabatier III, Toulouse, France.

Insights

Overall survival rates for hepatocellular carcinoma (HCC) curative treatments were similar on an intention-to-treat (ITT) basis. Key negative prognostic factors included not adhering to multidisciplinary team (MDT) decisions and elevated alpha-fetoprotein levels.

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Gastroenterology

Background:

  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Curative treatment options for HCC include liver transplantation (LT), radiofrequency ablation (RFA), and surgical resection (SR).
  • Assessing treatment efficacy on an intention-to-treat (ITT) basis is crucial for clinical decision-making.

Purpose of the Study:

  • To compare overall survival (OS) rates for LT, RFA, and SR in HCC patients.
  • To evaluate the impact of multidisciplinary team (MDT) decisions on treatment outcomes.
  • To identify prognostic factors influencing survival in HCC patients undergoing curative treatment.

Main Methods:

  • A cohort study was conducted using data from an HCC-dedicated multidisciplinary team meeting (MDT).
  • Patients diagnosed with HCC between 2006 and 2013, with a decided curative treatment (LT, RFA, or SR), were included.
  • Overall survival (OS) was analyzed on an intention-to-treat (ITT) basis.

Main Results:

  • Five-year OS rates on an ITT basis were comparable across LT (35%), RFA (32%), and SR (34%) groups (P=0.77).
  • Sixty-six percent of patients received their planned curative treatment.
  • Multivariate analysis identified non-adherence to MDT decisions (HR: 0.39), elevated alpha-fetoprotein (HR: 0.63), and exclusion from Milan criteria (HR: 0.45) as negative prognostic factors.

Conclusions:

  • Intention-to-treat (ITT) overall survival (OS) was similar for liver transplantation (LT), radiofrequency ablation (RFA), and surgical resection (SR) in hepatocellular carcinoma (HCC).
  • Adherence to multidisciplinary team (MDT) recommendations is critical for improving patient outcomes.
  • Elevated alpha-fetoprotein levels and exceeding Milan criteria significantly worsen prognosis in HCC patients.
Abstract